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What is Hepatocellular
Carcinoma (HCC)?
HCC is the most common liver
cancer
• It is the third most common cause
of cancer-related death in the
world and 7th in the United States
• Diagnosed late due to lack of
symptoms until terminal stages
• Most often occurs in people with
chronic liver disease

(Mayo, 2019, para. 1)
(Ghouri, 2017, para. 1)
(Daher, 2018, pp. 69-78)

(Mayo, 2019, image)

Etiology and Epidemiology
Majority of people with HCC already
have Hepatitis B and C
• Hepatitis-B virus - most common in
HCC patients
• Hepatitis-C virus - second most
common
Alcohol-related Cirrhosis is also
common among HCC patients
• Nonalcoholic Fatty Liver Disease
(NAFLD) is the third most
common disease that occurs
mainly in presence of cirrhosis,
found to be a cause of HCC.
HCC - most common among males
ages 30-50
• Accounts for 65% of all liver
(Ghouri, 2017, para. 3-10)
cancers in U.S.

Treatment Options
Different treatment options include:
• Surgical resection
• Liver transplantation
• Limited due to lack of
donors and strict
indications
• Radiofrequency ablation therapy
• Safety is dependent on
where the tumor is located
• Chemotherapy
• Radiation therapy
• Due to the liver's
sensitivity to radiation, this
is limited and has not
been thought of as an
effective option
• Stereotactic Body
Radiation Therapy, after
recent studies, shows
good local control rates
for primary and metastatic
liver cancers without risk
of radiation-induced liver
disease
• Targeted drug therapy
(Mayo, 2019, para. 4)
(Zhang, 2018, para. 1)
• Immunotherapy
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CyberKnife SBRT

(Radiation Therapy News, 2014, image)

• Ability to deliver precise treatments
within one millimeter
• More radiation is delivered to
precise target area while
preserving surrounding healthy
tissue
• System combines intra-operative
x-rays with previously acquired CT
images of lesion to target each
beam of radiation
• Real-time tracking accounts for
any movement and adjustments
are made to ensure dose is
delivered to treatment area
(CyberKnife, 2017, p. 7)
(Stanford, 2020, para. 5)

Stereotactic Body Radiation
Therapy (SBRT)
Pros:
• Enables delivery of high dose
radiation
• Surrounding healthy tissue dose
limited
• Shorter and less treatments make
poor performance patients easier
to treat
(Kato, 2015, pp. 13101-13112)

(Duttaradio, 2015, sl. 23)

CyberKnife SBRT
for HCC
CyberKnife (CK) is a good treatment
option for patients ineligible for other
main treatments.
It can be used for:
• pre-surgery therapy to down-stage
a tumor
• Preventing tumor growth
• Palliative therapy
It makes radiation therapy treatment
delivery extremely precise
• Limits exposure to healthy tissue
• Real-time tumor tracking makes
any adjustments for motion
In a study by Que et al., CK SBRT
appeared to be a viable treatment
option in patients with unresectable
HCC
• Low risk of severe toxicity
• 48.7% of patients had complete
response
• Overall survival at one and two
years was 63.5% and 41.3%,
(Daher, 2018, pp. 69-78)
respectively
(Que, 2016, pp. 1-10)

Conclusion
• HCC - most common liver cancer
and one of the most common
cancer-related deaths worldwide
• CK offers near exact precision with
treatment delivery using real-time
tumor tracking
• Being precise, makes radiation
therapy an effective & safe
treatment for patients
• Can be used palliatively, presurgically, and to prevent any tumor
(Que, 2016, pp. 1-10)
growth

(Daher, 2018, pp. 69-78)
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